Sudden death risk among children with epilepsy
Citation Manager Formats

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neurologists and pediatricians often make clinical recommendations without consideration of sudden unexplained death in epilepsy (SUDEP), do not consistently inform parents of the risks of SUDEP among their children with epilepsy, and often postpone facing the reality of SUDEP risk until their patients reach adulthood.1 On casual inspection, the literature reviewed in a recent guideline might reinforce some clinicians' practice of delaying these unpleasant SUDEP-related decisions and discussions until adulthood.2 Until recently, the reported SUDEP rate among children during their first 18 years of life (1 per 4,500/y) was about one-fourth to one-fifth that of the risk of SUDEP among adults with epilepsy (1 per 1,000/y).2 Yet the emerging evidence regarding SUDEP incidence among children is changing, especially among children with intractable epilepsy, and should prompt a change in physician practice and generate more research.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See Page 60
- © 2018 American Academy of Neurology
AAN Members: Sign in with your AAN member credentials (e-mail or 6-digit Member ID number)
Non-AAN Member subscribers: Sign in with subscriber credentials
Log in using your username and password
Purchase access
AAN members must change their passwords on the AAN site
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00.
Disputes & Debates: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.